Adapted from post by Angela Pereira originally on the ACTION blog
ACTION recently took a delegation of journalists to Indonesia to learn how the country is harnessing global support to transform their immunisation system. Check out the photo slideshow below, providing a glimpse of what we learned!
Powered by Cincopa Video Hosting for Business solution. Reporting from Indonesia: A Homegrown Vaccine Industry with Global Support 100 miles from the Indonesian capital of Jakarta lay Bandung, a city ringed by rolling green hills, filled with bustling markets and malls, and packed with raging traffic jams. Credit: Phalinn Ooi originaldate 1/1/0001 6:00:00 AM width 2048 height 1365 While it’s most known for its food and shopping, Bandung is also often referred to as Indonesia’s Silicon Valley, rapidly growing as a center of technological innovation in Indonesia. originaldate 1/1/0001 6:00:00 AM width 960 height 720 One hub of innovation in the city occupies a pristine green campus dotted with impressive colonial-style buildings. flash 24 cameramake Apple height 1283 orientation 1 camerasoftware 8.0.2 originaldate 12/3/2014 8:38:54 PM width 2048 cameramodel iPhone 6 Workers move around the 20-acre property with the busied look of people preoccupied by an important mission.But they aren’t writing code or developing new software, they’re working to develop and produce vaccines for every child in Indonesia. flash 24 cameramake BlackBerry height 1760 camerasoftware Adobe Photoshop Ligh originaldate 12/3/2014 9:39:52 PM width 2880 cameramodel BlackBerry Z10 In 1890, the Governor of the then Dutch East Indies established the ‘Parc Vaccinogene’ by decree. Now called BioFarma, the 124-year-old institution has undergone many transformations in its long history. Credit: Ferry Tan flash 16 cameramake Canon height 1544 camerasoftware Adobe Photoshop Ligh originaldate 12/3/2014 8:31:40 PM width 2088 cameramodel Canon EOS 5D Mark II But one current fact about BioFarma stands tall above its storied history: The state-owned company is one of the world’s largest vaccines manufacturers & suppliers, producing vaccines not only for the global market but for all children in Indonesia. flash 16 cameramake Canon height 1920 camerasoftware Adobe Photoshop Ligh originaldate 12/3/2014 8:45:32 PM width 2880 cameramodel Canon EOS 5D Mark II That’s no easy feat considering the country houses the fourth largest population in the world. Over 50,000 village midwives supervise routine immunizations in around 260,000 village health posts called ‘posyandus’. Credit: Ferry Tan flash 16 cameramake Canon height 1920 camerasoftware Adobe Photoshop Ligh originaldate 12/4/2014 3:16:24 PM width 2880 cameramodel Canon EOS 5D Mark II But even when vaccines are produced cost-effectively and locally, it’s still no easy feat to ensure vaccines make their way to children across Indonesia’s 6,000+ inhabited islands. That’s where Gavi, the Vaccine Alliance, has come in. Gavi has provided about $US 38 million to support Indonesia’s immunization system – including to upgrade the cold storage and vaccine delivery networks – and strengthen the wider health system. Credit: BioFarma flash 13 cameramake NIKON CORPORATION height 1000 orientation 1 camerasoftware Adobe Photoshop CS5. originaldate 9/5/2013 4:22:51 PM width 1500 cameramodel NIKON D3X And most recently, Gavi supported the introduction and rollout of the pentavalent vaccine across Indonesia. This intensive process began in August 2013 and is gradually reaching across the entire country. Credit: BioFarma flash 13 cameramake NIKON CORPORATION height 1000 orientation 1 camerasoftware Adobe Photoshop CS5. originaldate 9/5/2013 9:03:35 PM width 1500 cameramodel NIKON D3X Why was this particular vaccine so important for Indonesia? Here’s one reason: The pentavalent vaccine protects against diphtheria-tetanus-pertussis, hepatitis B, and Hib all in one shot. In a country where many people live in rural & hard-to-reach areas, minimizing the number of health center visits needed to protect kids from preventable diseases is essential. Credit: BioFarma flash 16 cameramake Canon height 1920 camerasoftware Adobe Photoshop Ligh originaldate 12/4/2014 3:13:16 PM width 2880 cameramodel Canon EOS 5D Mark II Gavi’s support for pentavalent will end in 2016, when financing will be taken over by the Indonesian government. In general, Indonesia is one of 20 countries on a path of ‘graduation’ from Gavi support. It often takes external finance to jumpstart the introduction of vaccines because that’s a big step for a country to take. — Seth Berkley, Gavi CEO flash 13 cameramake NIKON CORPORATION height 1000 orientation 1 camerasoftware Adobe Photoshop CS5. originaldate 9/5/2013 8:44:20 PM width 1500 cameramodel NIKON D3X Gavi, the Vaccine Alliance, has supported Indonesia’s efforts to reach every child with vaccines, but the moment for the world to support Gavi is rapidly approaching. On January 27, Gavi will look to raise $7.5 billion in new commitments from donors like the United States, France and Australia. To support countries like Indonesia to vaccinate 300 million children by 2020, preventing 5 to 6 million deaths. What will they use it for?
But this US$7.5 billion figure is likely to be the highest level of funding Gavi will need. While donor governments will contribute pledges to Gavi, countries that receive support must match a portion of costs. As a country’s economy grows, so too does its share.
Indonesia is one of 20 countries already on the path to ‘graduation’ from Gavi support.
ACTION and RESULTS in working to ensure Gavi raises the funding it needs to accelerate its progress from 2016-2020. Curious how Australia is already performing on its current contributions and pledges to Gavi? Check out our “ Donor Immunization Record“.
To ensure Gavi is fully funded to save an estimated 5 – 6 million lives by 2020, RESULTS Australia is calling on our government to pledge at least $100 million per year.